Enorama Pharma AB's market cap is currently kr208.85M. The company's EPS TTM is kr-0.179; its P/E ratio is ―; Enorama Pharma AB is scheduled to report earnings on November 19, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
